Pharmacology Watch – March 1, 2016
March 1, 2016
View Issues
-
Updated Antithrombotic Therapy Guidelines Released
The guideline contains some significant changes from the previous CHEST guidelines.
-
Study: No Link Between Dementia, Benzodiazepine Use
New research upends previous beliefs.
-
New Recommendations for Bisphosphonate Therapy
For women who are not at high risk after 3-5 years of bisphosphonate therapy, a drug holiday of 2-3 years may be considered.
-
Promising Treatment Not Widely Available
Among adults with recurrent or refractory Clostridium difficile infection, the use of frozen compared with fresh fecal microbiota transplantation did not result in worse proportion of clinical resolution of diarrhea.
-
Time to Limit Proton Pump Inhibitors?
A new study suggests the commonly used drugs may be associated with chronic kidney disease.
-
FDA Actions
The FDA has approved a new fixed-dose combination oral, once-daily pill to treat hepatitis C genotypes 1 and 4.